The Pharmaletter
One To Watch
CODA Biotherapeutics
"CODA Biotherapeutics, Inc., is a preclinical-stage biopharmaceutical company developing an innovative gene therapy platform to treat many disorders and diseases."
"The company is using a revolutionary chemogenetics-based technology to modulate the activity of pathological cells. CODA is located in South San Francisco, CA."
Latest CODA Biotherapeutics News
9 March 2022
5 February 2020
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze